Position in ANIK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$211,213
-$40,126 QoQ
Shares Held
14,437
-44.8% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 134 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $1,140,219,030 across 49 Drug Manufacturers - Specialty & Generic names. ANIK ranks #45 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
409,074 | $221,648,565 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3,853,212 | $179,212,890 | |
| 3 | ZTS |
Zoetis Inc.
|
1,813,759 | $130,336,721 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,265,321 | $110,629,075 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,098,945 | $86,119,713 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,725,889 | $67,084,128 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
507,207 | $41,986,595 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
336,399 | $37,320,105 |
All Filings in ANIK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $211,213 | 14,437 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $251,339 | 26,154 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $816,615 | 86,874 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,414,260 | 133,673 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,165,546 | 77,548 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $419,779 | 25,503 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $975,872 | 39,509 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $777,934 | 30,712 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,948,762 | 116,093 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,424,367 | 327,642 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,703,661 | 574,539 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,397,560 | 130,776 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $233,120 | 8,117 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,846,845 | 129,961 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $234,882 | 9,869 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $822,826 | 36,865 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $1,086,544 | 30,325 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,329,744 | 31,244 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,924,327 | 44,452 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,030,467 | 123,326 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,099,365 | 24,290 | Shares | Sole | 2021-02-16 | |
| 2020-03-31 | $1,712,512 | 59,236 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||